drugset / Trial / NCT00731757
Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and efficacy of Humira in the treatment of cutaneous sarcoidosis.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |